Invested in Sustainable Value Creation

Wavelength’s Operating Executives specialize in the
nexus of Lifesciences, Healthcare, and Technology.

We focus on delivering sustainable value...
not on account development.

Expertise Bound With Long Term Perspective

Wavelength’s Operating Executives specialize in the nexus of Lifesciences, Healthcare, and Technology. We deliver transformations resulting in sustainable business value.

We solve complex problems with small teams possessing deep industry expertise. Rolling up our sleeves, we get our hands dirty and work quickly to distill and resolve your needs - driven by an energy and passion for great results. You can count on us to introduce fresh, sound ideas tempered by an experience-tested dose of realism. We always align with our business partners through shared interests.

Our approach will be most refreshing if you’ve ever been oversupplied with high dollar, marginal talent, sold work that didn’t move the needle on the business, or received a strategic plan filled with bright, but flawed and non-implementable ideas.

We’ve held many roles - executives, entrepreneurs, and consultants. These experiences mean we have seen numerous scenarios from multiple viewpoints. You will never have to question our loyalty. When you partner with us, it’s your agenda, period.

If all this resonates with you, then we are

... on your Wavelength

Global News in Lifesciences, Healthcare, and Technology

Actos Deemed as Safe as Avandia

Results from a new study reveal that patients taking Takeda's diabetes treatment Actos have the same rate and kind of side effects as GSK's embattled Avandia. Is this a good sign?

Simple Finance Technology Corp. Raises $2.9M Series A from First Round Capital and Others

The new, online bank, BankSimple, a subsidiary of Simple Finance Technology Corp., has closed a $2.9 million Series A round from First Round Capital, IA Ventures and Village Ventures led the round, with support from Jerry Neumann, SV Angel, Nauiokas Park and several, as yet, unannounced angel investors. PRESS RELEASE: Simple Finance Technology Corp., the makers of [...]

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)

Celldex to Advance Rindopepimut Clinical Program Management to Host Conference Call Today at 8:30 AM Eastern Time NEEDHAM, Mass., Sept. 3 (HSMN NewsFeed) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX ) announced today it will regain full worldwide rig...
Biopharmaceuticals, Oncology
Celldex Therapeutics, Pfizer, Pfizer Vaccines, rindopepimut

Ford's Electric Vision: New Hybrids, 700 Mile-Range PHEV by 2012

We catch up with Ford on how it intends to make electric vehicles a smart buy for consumers

Lilly Kills Two Alzheimer's Trials

In a huge blow to Eli Lilly's Alzheimer's pipeline, the drug giant was forced to end two clinical trials due to the fact that the treatment was actually making patients' memory recall worse.

Offerpal Gets New CEO, Mihir Shah; George Garrick Made Executive Chairman

Offerpal Media, which helps games publishes make money by delivering an array of trial offers to their customers at the point of sale, just announced that Mirhir Shah has been named CEO. No reason was given for the appointment of chairman and former CEO George Garrick to executive chairman. PRESS RELEASE: Offerpal Media, the leader in social [...]

Accentus Medical Signs Global Licence Agreement with Zimmer

OXFORD, England--(Healthcare Sales & Marketing Network)--Accentus Medical, a leading UK medical technology company that supplies advanced coatings and surface treatments to the medical device industry, announced today that it has signed a Licence and Servi...
Devices, Orthopaedic, Licensing
Accentus Medical, Zimmer Holdings, Agluna

9/03/2010 Daily Hardware Reviews

DailyTech's roundup of hardware reviews from around the web for Friday